OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $468.19 million. The enterprise value is $516.87 million.
Important Dates
The last earnings date was Thursday, February 26, 2026, after market close.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 25.08 million shares outstanding. The number of shares has increased by 1.65% in one year.
| Current Share Class | 25.08M |
| Shares Outstanding | 25.08M |
| Shares Change (YoY) | +1.65% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 5.19% |
| Owned by Institutions (%) | 61.82% |
| Float | 15.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.98 |
| Forward PS | 1.75 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 2.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.55, with a Debt / Equity ratio of 0.32.
| Current Ratio | 5.55 |
| Quick Ratio | 2.48 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.84 |
Financial Efficiency
Return on equity (ROE) is -11.31% and return on invested capital (ROIC) is -4.07%.
| Return on Equity (ROE) | -11.31% |
| Return on Assets (ROA) | -3.69% |
| Return on Invested Capital (ROIC) | -4.07% |
| Return on Capital Employed (ROCE) | -6.27% |
| Weighted Average Cost of Capital (WACC) | 9.22% |
| Revenue Per Employee | $420,548 |
| Profits Per Employee | -$70,548 |
| Employee Count | 562 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 0.51 |
Taxes
In the past 12 months, OrthoPediatrics has paid $460,000 in taxes.
| Income Tax | 460,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.60% in the last 52 weeks. The beta is 1.11, so OrthoPediatrics's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -19.60% |
| 50-Day Moving Average | 17.68 |
| 200-Day Moving Average | 19.12 |
| Relative Strength Index (RSI) | 60.80 |
| Average Volume (20 Days) | 132,767 |
Short Selling Information
The latest short interest is 931,793, so 3.72% of the outstanding shares have been sold short.
| Short Interest | 931,793 |
| Short Previous Month | 990,998 |
| Short % of Shares Out | 3.72% |
| Short % of Float | 6.02% |
| Short Ratio (days to cover) | 6.57 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $236.35 million and -$39.65 million in losses. Loss per share was -$1.69.
| Revenue | 236.35M |
| Gross Profit | 172.66M |
| Operating Income | -29.00M |
| Pretax Income | -39.19M |
| Net Income | -39.65M |
| EBITDA | -7.88M |
| EBIT | -29.00M |
| Loss Per Share | -$1.69 |
Full Income StatementBalance Sheet
The company has $60.85 million in cash and $109.53 million in debt, with a net cash position of -$48.68 million or -$1.94 per share.
| Cash & Cash Equivalents | 60.85M |
| Total Debt | 109.53M |
| Net Cash | -48.68M |
| Net Cash Per Share | -$1.94 |
| Equity (Book Value) | 346.60M |
| Book Value Per Share | 13.81 |
| Working Capital | 210.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.85 million and capital expenditures -$11.11 million, giving a free cash flow of -$15.96 million.
| Operating Cash Flow | -4.85M |
| Capital Expenditures | -11.11M |
| Free Cash Flow | -15.96M |
| FCF Per Share | -$0.64 |
Full Cash Flow StatementMargins
Gross margin is 73.05%, with operating and profit margins of -12.27% and -16.78%.
| Gross Margin | 73.05% |
| Operating Margin | -12.27% |
| Pretax Margin | -16.58% |
| Profit Margin | -16.78% |
| EBITDA Margin | -3.33% |
| EBIT Margin | -12.27% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.65% |
| Shareholder Yield | -1.65% |
| Earnings Yield | -8.47% |
| FCF Yield | -3.41% |
Analyst Forecast
The average price target for OrthoPediatrics is $24.67, which is 32.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.67 |
| Price Target Difference | 32.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 12.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 1.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | 3 |
